FDA Adverse Event Injury Summary report: N

SYNCHROMED II

MDR report key: 3449815 · Received November 5, 2013

Report

Report Number
3007566237-2013-03584
Event Type
Injury
Date Received
November 5, 2013
Date of Event
June 20, 2013
Report Date
October 7, 2013
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID NEU_UNKNOWN_CATH, LOT# UNKNOWN, PRODUCT TYPE: CATHETER. (B)(4).

Description of Event or Problem · 1

TEODORCZYK, J,. SZMUDA, T., SIEMINSKI, M., LASS, P., STONIEWSKI, P. ET.AL. EVALUATION OF USEFULNESS OF SCINTIGRAPHIC IMAGING IN DIAGNOSIS OF INTRATHECAL DRUG DELIVERY SYSTEM MALFUNCTION - A PRELIMINARY REPORT. POLISH JOURNAL OF RADIOLOGY. 2013. 78(3) SUMMARY/REPORTED EVENT: THIS REPORT REFERS TO A (B)(6) MALE PATIENT. INTRATHECAL BACLOFEN (ITB) SYSTEM IMPLANTED 5 YEARS EARLIER (SYNCHROMED I 20 ML - MEDTRONIC, (B)(4)). THE PATIENT RECEIVED BACLOFEN INTRATHECAL (MANUFACTURER UNKNOWN) FOR SPASTIC PARAPARESIS OF UNKNOWN ETIOLOGY AT AN UNKNOWN DATE AND DOSE. GRADUAL REDUCTION OF THERAPEUTIC EFFECT OF INTRATHECAL BACLOFEN WAS OBSERVED FOR 2 YEARS. SCINTIGRAPHY SHOWED HIGH ACTIVITY OF TRACER IN BODY FLUIDS, NO TRACER IN SPINAL CANAL. DUE TO HIGH SENSITIVITY OF SCINTIGRAPHY, APPEARANCE OF CONSIDERABLE RADIOTRACER AMOUNT IN BLOOD, SOFT TISSUES AND URINARY BLADDER WAS CHARACTERISTIC FOR A LEAK (NO NEED TO SEE POOLING OF RADIOTRACER NEAR LEAKAGE PLACE). CATHETER SYSTEM IN THIS PATIENT WAS LATER REPAIRED INTRAOPERATIVELY. AUTHOR CONCLUDED THAT RADIOLOGIC ASSESSMENT OF INTRATHECAL DRUG DELIVERY SYSTEMS (IDDS) SYSTEM WAS ESSENTIAL. IT FACILITATES FINAL DIAGNOSIS IN MANY CASES, WAS BROADLY AVAILABLE AND CARRIES BASIC MORPHOLOGIC INFORMATION NEEDED FOR INTERPRETATION OF FUNCTIONAL RADIOISOTOPIC STUDIES OR LATER SURGICAL INTERVENTION. SCINTIGRAPHIC IMAGING SEEMED TO BE A VALUABLE FUNCTIONAL ADJUNCT TO FIRST-LINE MORPHOLOGICAL STUDIES ENABLING FINAL DIAGNOSIS IN MANY PATIENTS WITH POTENTIAL MALFUNCTION OF INTRATHECAL DRUG DELIVERY SYSTEMS (IDDS). FURTHER STUDIES ENCOMPASSING HIGHER NUMBER OF PATIENTS WERE NECESSARY TO DEFINE THE EXACT DIAGNOSTIC ACCURACY. SEE LITERATURE ARTICLE ATTACHED TO MANUFACTURER REPORT 3007566237-2013-03582.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
569324 SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION 8637

Patients

Seq Age Sex Outcome Treatment
1 00028 YR Required Intervention